{
    "nct_id": "NCT03964259",
    "official_title": "Pilot Study on the Reduced Intravenous Fluids to Improve Clearance of High-Dose Methotrexate (HDMTX) in Children With Lymphoma or Acute Lymphoblastic Leukemia",
    "inclusion_criteria": "* Diagnosis of lymphoma or acute lymphoblastic leukemia\n* Candidate for a minimum of 2 cycles HDMTX (5 g/m2) in the inpatient setting\n* Creatinine clearance â‰¥ 65 mL/min by modified Schwartz equation\n* Patients of childbearing potential must have a negative pregnancy test (serum or urine)\n* Lactating female patients must agree not to nurse a child while on this trial\n* All patients and/or their parents or legal guardians must provide written informed consent, with assent provided if applicable\nHealthy volunteers allowed\nMust have minimum age of 1 Year\nMust have maximum age of 17 Years",
    "exclusion_criteria": "* Trisomy 21\n* History of dialysis within 30 days prior to study registration or currently on dialysis\n* Polyuric renal dysfunction\n* Pregnancy\n* Known or suspected pleural effusion\n* Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements",
    "miscellaneous_criteria": ""
}